TR201003856A1 - Aktif ajan olarak sefiksim içeren suda çözünebilir formülasyon. - Google Patents

Aktif ajan olarak sefiksim içeren suda çözünebilir formülasyon.

Info

Publication number
TR201003856A1
TR201003856A1 TR2010/03856A TR201003856A TR201003856A1 TR 201003856 A1 TR201003856 A1 TR 201003856A1 TR 2010/03856 A TR2010/03856 A TR 2010/03856A TR 201003856 A TR201003856 A TR 201003856A TR 201003856 A1 TR201003856 A1 TR 201003856A1
Authority
TR
Turkey
Prior art keywords
water soluble
active agent
formulation containing
soluble formulation
containing cefixime
Prior art date
Application number
TR2010/03856A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/03856A priority Critical patent/TR201003856A1/tr
Publication of TR201003856A1 publication Critical patent/TR201003856A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Mevcut buluş, sefiksim içeren suda çözünebilir toz, tablet ve granul formülasyonlarına ilişkindir.
TR2010/03856A 2009-12-25 2010-05-14 Aktif ajan olarak sefiksim içeren suda çözünebilir formülasyon. TR201003856A1 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2010/03856A TR201003856A1 (tr) 2009-12-25 2010-05-14 Aktif ajan olarak sefiksim içeren suda çözünebilir formülasyon.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2009/09786A TR200909786A1 (tr) 2009-12-25 2009-12-25 Sefiksim içeren efervesan tablet ve granül formülasyonu.
TR2010/03856A TR201003856A1 (tr) 2009-12-25 2010-05-14 Aktif ajan olarak sefiksim içeren suda çözünebilir formülasyon.

Publications (1)

Publication Number Publication Date
TR201003856A1 true TR201003856A1 (tr) 2011-08-22

Family

ID=43532584

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2009/09786A TR200909786A1 (tr) 2009-12-25 2009-12-25 Sefiksim içeren efervesan tablet ve granül formülasyonu.
TR2010/03856A TR201003856A1 (tr) 2009-12-25 2010-05-14 Aktif ajan olarak sefiksim içeren suda çözünebilir formülasyon.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2009/09786A TR200909786A1 (tr) 2009-12-25 2009-12-25 Sefiksim içeren efervesan tablet ve granül formülasyonu.

Country Status (3)

Country Link
EP (1) EP2515849A1 (tr)
TR (2) TR200909786A1 (tr)
WO (2) WO2011078821A1 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8962041B2 (en) * 2013-02-12 2015-02-24 Johnson & Johnson Consumer Companies, Inc. Methods and compositions for enhancing hair quality using blackberry extract
CN103494821B (zh) * 2013-10-01 2018-09-25 迪沙药业集团有限公司 一种头孢克肟组合物
CN104366648A (zh) * 2014-10-21 2015-02-25 宣城柏维力生物工程有限公司 甜橙vc泡腾片
CN111544412B (zh) * 2020-04-17 2022-06-24 广州白云山医药集团股份有限公司白云山制药总厂 头孢克肟组合物及其制备方法
CN113440530B (zh) * 2021-07-08 2023-08-08 广州白云山医药集团股份有限公司白云山制药总厂 一种头孢克肟药物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409214A (en) 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
ES2061623T3 (es) 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
ATE216887T1 (de) * 1996-02-29 2002-05-15 Fujisawa Pharmaceutical Co Beta-lactam-antibiotikum enthaltende tabletten und verfahren zu deren herstellung
CN100417383C (zh) * 2006-03-07 2008-09-10 中国药科大学 一种含有头孢克肟的泡腾片及制法
CN101606913B (zh) * 2009-07-16 2012-12-19 广州白云山制药股份有限公司广州白云山制药总厂 头孢克肟分散片及其制备方法

Also Published As

Publication number Publication date
EP2515849A1 (en) 2012-10-31
WO2011078832A1 (en) 2011-06-30
TR200909786A1 (tr) 2011-07-21
WO2011078821A1 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
AU2012265219A8 (en) Compounds containing hydrido-tricyano-borate anions
MX348823B (es) Formulaciones estables de linaclotida.
WO2010021607A3 (en) Pharmaceutical formulation
UA103025C2 (ru) Твердая композиция лекарственного средства замедленного высвобождения
MX2013006418A (es) Derivados de oxazolil-metileter como agonistas del receptor de alx.
TR201003856A1 (tr) Aktif ajan olarak sefiksim içeren suda çözünebilir formülasyon.
MX2010004962A (es) Mezclas homogeneas y estables en almacenamiento de diferentes particulas de granulos de agentes activos protectores de plantas.
WO2011142731A3 (en) Formulations comprising a third generation cephalosporin and clavulanic acid
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
ATE451097T1 (de) Valsartanformulierungen
WO2011139252A3 (en) Efervescent formulations comprising cefdinir
BR112013028607A2 (pt) composições sólidas contendo éter glicólico e água
SI2590620T1 (sl) Stabilne vodne formulacije, ki vsebujejo v vodi slabo topne učinkovine
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
WO2011093831A3 (en) Effervescent formulations comprising cefprozil as active agent
WO2012174164A3 (en) Agonists of gpr131 and uses thereof
GB2501427A (en) A washing capsule for providing washing compositions to a machine
GEP201706769B (en) Composition of tiacumicin compounds
TR201009399A2 (tr) Hızlı çözünen efervesan rosuvastatin formülasyonları.
TR201010859A2 (tr) Sefdinir içeren tablet formları.
TR201109160A2 (tr) Eplerenon içeren yeni farmasötik kompozisyonlar.
WO2010146313A3 (fr) Utilisation d'une composition comprenant de la nacre et éventuellement des principes actifs de cocos nucifera comme milieu nutritif dilueur de cellules reproductrices